The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for L Maes


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.EBI
Mercachem
Synthesis and bioactivity ofß-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.EBI
Universiteit Gent
Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).EBI
University of Antwerp
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.EBI
University of Antwerp (Ua)
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.EBI
University of Lille
Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.EBI
University of Lille
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.EBI
Vu University Amsterdam
Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones.EBI
Ghent University
Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds.EBI
University of Lille
Design and evaluation of Trypanosoma brucei metacaspase inhibitors.EBI
University of Antwerp
Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal.EBI
University of Auckland
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis.EBI
Drugs For Neglected Diseases Initiative (Dndi)
Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.EBI
Université
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.EBI
Umr 8525 Cnrs-Université
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds.EBI
University of Antwerp
Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.EBI
Cardiff University
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).EBI
Vrije Universiteit Amsterdam
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors.EBI
Vrije Universiteit Amsterdam
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.EBI
University of London
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.EBI
Vrije Universiteit Amsterdam
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.EBI
University of Auckland
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.EBI
University of Auckland